The use of lasers in the pediatric population

K Mariwalla1, J S Dover

  • 1Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Skin Therapy Letter
|November 18, 2005
PubMed

Insights

Laser therapy offers advancements for pediatric birthmarks like port wine stains and hemangiomas. Clinical experience guides understanding of its efficacy, benefits, and potential side effects in children.

Area of Science:

  • Pediatric Dermatology
  • Dermatologic Surgery
  • Laser Medicine

Background:

  • Recent decades show significant progress in laser treatments for pediatric birthmarks.
  • Lingering questions persist regarding the effectiveness, overall advantages, and adverse effects of these therapies.

Purpose of the Study:

  • To present expert opinion on the application of lasers for treating common pediatric birthmarks.
  • To address ongoing concerns about laser therapy outcomes in children.

Main Methods:

  • Clinical experience spanning decades.
  • Review of laser therapy applications for specific pediatric vascular and pigmented lesions.

Main Results:

  • The study offers insights based on extensive clinical practice.
  • Highlights the role of lasers in managing port wine stains, superficial hemangiomas, and café au lait macules.

Conclusions:

  • Laser therapy remains a key modality for treating pediatric birthmarks.
  • Continued evaluation of efficacy and safety is essential for optimizing patient care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...